KLINIK FOR TAND-, MUND- OG KÆBEKIRURGI I/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  1.9% 4.8% 5.5% 7.4% 6.4%  
Credit score (0-100)  71 45 40 32 36  
Credit rating  A BBB BBB BB BBB  
Credit limit (kDKK)  2.4 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  9,799 16,230 17,038 20,423 19,401  
EBITDA  5,894 12,038 12,356 13,993 10,764  
EBIT  4,213 10,361 10,765 12,776 9,537  
Pre-tax profit (PTP)  4,146.1 10,054.0 10,424.9 12,250.3 9,037.6  
Net earnings  4,146.1 10,054.0 10,424.9 12,250.3 9,037.6  
Pre-tax profit without non-rec. items  4,146 10,054 10,425 12,250 9,038  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  6,275 5,097 4,281 4,081 3,405  
Shareholders equity total  5,907 8,243 4,913 4,182 3,008  
Interest-bearing liabilities  535 424 224 66.8 419  
Balance sheet total (assets)  7,582 9,807 6,266 5,207 4,918  

Net Debt  418 -3,516 -688 -338 -171  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  9,799 16,230 17,038 20,423 19,401  
Gross profit growth  -15.2% 65.6% 5.0% 19.9% -5.0%  
Employees  10 10 10 12 15  
Employee growth %  -9.1% 0.0% 0.0% 20.0% 25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,582 9,807 6,266 5,207 4,918  
Balance sheet change%  -30.6% 29.3% -36.1% -16.9% -5.5%  
Added value  5,894.3 12,038.2 12,356.3 14,367.5 10,764.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -2,507 -2,855 -2,407 -1,418 -1,903  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  43.0% 63.8% 63.2% 62.6% 49.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  45.6% 119.2% 134.0% 222.8% 188.5%  
ROI %  50.4% 134.6% 156.1% 272.3% 248.6%  
ROE %  56.1% 142.1% 158.5% 269.4% 251.4%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  77.9% 84.0% 78.4% 80.3% 61.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  7.1% -29.2% -5.6% -2.4% -1.6%  
Gearing %  9.1% 5.1% 4.6% 1.6% 13.9%  
Net interest  0 0 0 0 0  
Financing costs %  8.7% 65.1% 107.3% 364.9% 207.8%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.5 3.6 1.2 0.8 0.6  
Current Ratio  0.8 3.7 1.4 0.9 0.7  
Cash and cash equivalent  117.3 3,940.4 911.9 405.0 589.3  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -218.4 3,346.2 484.1 -61.9 -560.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  589 1,204 1,236 1,197 718  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  589 1,204 1,236 1,166 718  
EBIT / employee  421 1,036 1,076 1,065 636  
Net earnings / employee  415 1,005 1,042 1,021 603